Dietary Advanced Glycation End Products: Their Role in the Insulin Resistance of Aging
Cells · 2023
DOI: 10.3390/cells12131684 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Manuel Portero-Otin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Medicina Experimental, Facultad de Medicina, Universidad de Lleida, 25196 Lleida, Spain. Hauptthemen laut MEDLINE: Insulin Resistance. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Insulin resistance (IR) is commonly observed during aging and is at the root of many of the chronic nontransmissible diseases experienced as people grow older. Many factors may play a role in causing IR, but diet is undoubtedly an important one. Whether it is total caloric intake or specific components of the diet, the factors responsible remain to be confirmed. Of the many dietary influences that may play a role in aging-related decreased insulin sensitivity, advanced glycation end products (AGEs) appear particularly important. Herein, we have reviewed in detail in vitro, animal, and human evidence linking dietary AGEs contributing to the bodily burden of AGEs with the development of IR. We conclude that numerous small clinical trials assessing the effect of dietary AGE intake in combination with strong evidence in many animal studies strongly suggest that reducing dietary AGE intake is associated with improved IR in a variety of disease conditions. Reducing AGE content of common foods by simple changes in culinary techniques is a feasible, safe, and easily applicable intervention in both health and disease. Large-scale clinical trials are still needed to provide broader evidence for the deleterious role of dietary AGEs in chronic disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Medicina Experimental, Facultad de Medicina, Universidad de Lleida, 25196 Lleida, Spain.
- Centro de Nutricion y Diabetes, Departamento de Medicina, Clinica Alemana, Universidad del Desarrollo, Santiago 7610658, Chile.
- Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10021, USA.
ORCID-Profile: Manuel Portero-Otin, Jaime Uribarri
Zitieren
APA
Portero-Otin, M., de la Maza, M. P., & Uribarri, J. (2023). Dietary Advanced Glycation End Products: Their Role in the Insulin Resistance of Aging. Cells. https://doi.org/10.3390/cells12131684
Vancouver
Portero-Otin M, de la Maza MP, Uribarri J. Dietary Advanced Glycation End Products: Their Role in the Insulin Resistance of Aging. Cells. 2023. doi:10.3390/cells12131684
BibTeX
@article{PorteroOtin2023,
author = {Portero-Otin, Manuel and de la Maza, M Pia and Uribarri, Jaime},
title = {Dietary Advanced Glycation End Products: Their Role in the Insulin Resistance of Aging},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12131684}
}
EUVIMED